Literature DB >> 15008257

Genetic and environmental aspect of polycystic ovary syndrome.

E Carmina1.   

Abstract

Polycystic ovary syndrome (PCOS) is a heterogeneous syndrome determined in most patients by the association of two main factors: hyperandrogenism and insulin resistance. These characters are probably independent of each other and seem to be inherited by several different mechanisms. In some patients homozygous gene alteration has been found but in most patients PCOS seems to be determined by the association of gene polymorphisms that are common in the general population but alone are unable to determine phenotypic consequences. Alteration of genes that regulate the initial steps of ovarian steroidogenesis is probably the main causal factor of hyperandrogenism. Insulin resistance may be the result of many different gene alterations including insulin receptor substrate (IRS)-1 and 2, calpain-10 and peroxisome proliferator-activated receptor gamma(PPARgamma). Some polymorphisms may be protective against other gene alterations. Insulin sensitivity is also modified by socioeconomic and cultural factors that influence quantity and quality of food and energy expenditure. However, even eating behavior and weight response to food intake may be under genetic regulation. Different combinations of multiple gene polymorphisms and of environmental factors explain the heterogeneity of PCOS.

Entities:  

Mesh:

Year:  2003        PMID: 15008257     DOI: 10.1007/BF03345266

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  74 in total

Review 1.  Candidate genes in polycystic ovary syndrome.

Authors:  S Franks; N Gharani; M McCarthy
Journal:  Hum Reprod Update       Date:  2001 Jul-Aug       Impact factor: 15.610

Review 2.  Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

Authors:  D A Ehrmann; R B Barnes; R L Rosenfield
Journal:  Endocr Rev       Date:  1995-06       Impact factor: 19.871

3.  Evidence for gene-nutrient interaction at the PPARgamma locus.

Authors:  J Luan; P O Browne; A H Harding; D J Halsall; S O'Rahilly; V K Chatterjee; N J Wareham
Journal:  Diabetes       Date:  2001-03       Impact factor: 9.461

4.  Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome.

Authors:  D M Waterworth; S T Bennett; N Gharani; M I McCarthy; S Hague; S Batty; G S Conway; D White; J A Todd; S Franks; R Williamson
Journal:  Lancet       Date:  1997-04-05       Impact factor: 79.321

Review 5.  Polycystic ovary syndrome.

Authors:  S Franks
Journal:  N Engl J Med       Date:  1995-09-28       Impact factor: 91.245

6.  Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells.

Authors:  J K Wickenheisser; P G Quinn; V L Nelson; R S Legro; J F Strauss; J M McAllister
Journal:  J Clin Endocrinol Metab       Date:  2000-06       Impact factor: 5.958

7.  Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians.

Authors:  Søren K Rasmussen; Søren A Urhammer; Lars Berglund; Jan N Jensen; Lars Hansen; Søren M Echwald; Knut Borch-Johnsen; Yukio Horikawa; Hirosato Mashima; Hans Lithell; Nancy J Cox; Torben Hansen; Graeme I Bell; Oluf Pedersen
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

8.  Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome.

Authors:  David A Ehrmann; Peter E H Schwarz; Manami Hara; Xu Tang; Yukio Horikawa; Jacqueline Imperial; Graeme I Bell; Nancy J Cox
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

Review 9.  Nuclear receptors and the control of metabolism.

Authors:  Gordon A Francis; Elisabeth Fayard; Frédéric Picard; Johan Auwerx
Journal:  Annu Rev Physiol       Date:  2002-05-01       Impact factor: 19.318

10.  Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome.

Authors:  David A Ehrmann; Xu Tang; Issei Yoshiuchi; Nancy J Cox; Graeme I Bell
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

View more
  10 in total

1.  Associations of adiponectin gene polymorphisms with polycystic ovary syndrome: a meta-analysis.

Authors:  Hongxia Jia; Lili Yu; Xuxiao Guo; Wei Gao; Zhaoshun Jiang
Journal:  Endocrine       Date:  2012-01-22       Impact factor: 3.633

2.  Genetic analysis of the follicle stimulating hormone receptor gene in women with polycystic ovary syndrome.

Authors:  F Orio; E Ferrarini; T Cascella; A Dimida; S Palomba; E Gianetti; A Colao; P Agretti; P Vitti; G Lombardi; A Pinchera; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

3.  Socioeconomic status and polycystic ovary syndrome.

Authors:  Sharon Stein Merkin; Ricardo Azziz; Teresa Seeman; Ronit Calderon-Margalit; Martha Daviglus; Catarina Kiefe; Karen Matthews; Barbara Sternfeld; David Siscovick
Journal:  J Womens Health (Larchmt)       Date:  2011-02-16       Impact factor: 2.681

4.  Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.

Authors:  L Sun; H Lv; W Wei; D Zhang; Y Guan
Journal:  J Endocrinol Invest       Date:  2009-07-28       Impact factor: 4.256

5.  A Comprehensive Analysis of Body Mass Index Effect on in Vitro Fertilization Outcomes.

Authors:  Veronica Sarais; Luca Pagliardini; Giorgia Rebonato; Enrico Papaleo; Massimo Candiani; Paola Viganò
Journal:  Nutrients       Date:  2016-02-23       Impact factor: 5.717

6.  Healthy eating index in women with polycystic ovary syndrome: A case-control study.

Authors:  Mahbobeh Sadat Hosseini; Alireza Dizavi; Hosein Rostami; Karim Parastouei; Saeed Esfandiari
Journal:  Int J Reprod Biomed       Date:  2017-09

7.  Antioxidant effect of genistein on ovarian tissue morphology, oxidant and antioxidant activity in rats with induced polycystic ovary syndrome.

Authors:  Samira Rajaei; Alireza Alihemmati Ph D; Ali Abedelahi Ph D
Journal:  Int J Reprod Biomed       Date:  2019-03-03

8.  Polycystic ovarian syndrome: Environmental/occupational, lifestyle factors; an overview

Authors:  Chaoba Kshetrimayum; Anupama Sharma; Vineet Vashistha Mishra; Sunil Kumar
Journal:  J Turk Ger Gynecol Assoc       Date:  2019-03-01

9.  Effects of Soy Isoflavones, Resistant Starch and Antibiotics on Polycystic Ovary Syndrome (PCOS)-Like Features in Letrozole-Treated Rats.

Authors:  Geethika S G Liyanage; Ryo Inoue; Mina Fujitani; Tomoko Ishijima; Taisei Shibutani; Keiko Abe; Taro Kishida; Shinji Okada
Journal:  Nutrients       Date:  2021-10-24       Impact factor: 5.717

10.  The effect of nutrient supplementation in the management of polycystic ovary syndrome-associated metabolic dysfunctions: A critical review

Authors:  Elif Günalan; Aylin Yaba; Bayram Yılmaz
Journal:  J Turk Ger Gynecol Assoc       Date:  2018-10-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.